_benefits-of-monoclonal-antibody-treatment-preview-1.jpg "Benefits of Monoclonal Antibody Treatment from monoclonal antibody market Video Screenshot Preview 1")
Gallery_benefits-of-monoclonal-antibody-treatment-preview-3.jpg "Benefits of Monoclonal Antibody Treatment from monoclonal antibody market Video Screenshot Preview 3")
Gallery_benefits-of-monoclonal-antibody-treatment-preview-hqdefault.jpg "Benefits of Monoclonal Antibody Treatment from monoclonal antibody market Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 4 minutes 38 seconds
👁 View: 781 times
Play Audio:👁 View: 781 times
Description:
Bloomberg Television
Bloomberg Television
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_antibody-drug-conjugate-adcs-killing-mouse-breast-cancer-cells.webp "Antibody Drug Conjugate (ADCs) killing mouse breast cancer cells. Left: antibody isotype non-specific for mouse breast cancer cells. Right: antibody specific for mouse breast cancer cells. nnOne of the main limitations associated with standard chemotherapy is the unspecific killing of healthy cells (e.g. rapidly dividing cells in the bone marrow) which is associated with high-dose requirement and low therapeutic indices.nnIn order to significantly reduce systemic side effects, it is fundamental")
_monoclonal-antibody-treatment-why-it39s-so-difficult-to-distribute.webp "Washington Post")
_monoclonal-antibodies-market-124-industry-data-analytics-124-ida.webp "Industry Data Analytics")
_antibody-drug-conjugate-adcs-killing-mouse-breast-cancer-cells.webp "Antibody Drug Conjugate (ADCs) killing mouse breast cancer cells. Left: antibody isotype non-specific for mouse breast cancer cells. Right: antibody specific for mouse breast cancer cells.nnOne of the main limitations associated with standard chemotherapy is the unspecific killing of healthy cells (e.g. rapidly dividing cells in the bone marrow) which is associated with high-dose requirement and low therapeutic indices.nnIn order to significantly reduce systemic side effects, it is fundamental t")
_cancer-monoclonal-antibodies-market-124-datam-intelligence.webp "DataM Intelligence")
_changing-strategies-in-the-39war-on-cancer39-part-2-the-complexities-in-manufacturing-highly-potent-anti-cancer-medic.webp "For decades, the hallmark of medical treatment for cancer and hematological malignancies has been intravenous cytotoxic chemotherapy. These drugs target rapidly dividing cells, including cancer cells and certain normal tissues. As a result, many patients experience the classic toxicities of alopecia, gastrointestinal symptoms, and myelosuppression. nnBut how we treat these diseases has changed dramatically in the past decades. While traditional cytotoxic chemotherapy remains the treatment of cho")
⏲ 12 min 47 sec ✓ 22-Jul-2016
_benefits-of-monoclonal-antibody-treatment.webp "Bloomberg Television")
_tiziana-life-sciences-has-potential-to-39revolutionise-treatment-in-monoclonal-antibodies-market39.webp "Proactive Investors")
⏲ 9 minutes 18 seconds 👁 4.7K
_antibody-drug-conjugate-adcs-killing-mouse-breast-cancer-cells.jpg)
_monoclonal-antibody-treatment-why-it39s-so-difficult-to-distribute.jpg)
_monoclonal-antibodies-market-124-industry-data-analytics-124-ida.jpg)
_antibody-drug-conjugate-adcs-killing-mouse-breast-cancer-cells.jpg)
_cancer-monoclonal-antibodies-market-124-datam-intelligence.jpg)
_changing-strategies-in-the-39war-on-cancer39-part-2-the-complexities-in-manufacturing-highly-potent-anti-cancer-medic.jpg)
_benefits-of-monoclonal-antibody-treatment.jpg)
_tiziana-life-sciences-has-potential-to-39revolutionise-treatment-in-monoclonal-antibodies-market39.jpg)
![[+]](/images/menu.gif){kind=small}